Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 729

The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.

The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update

Open access
van Rheenen, Patrick F, Aloi, Marina, Assa, Amit, Bronsky, Jiri, Escher, Johanna C, Fagerberg, Ulrika L, Gasparetto, Marco, Gerasimidis, Konstantinos, Griffiths, Anne, Henderson, Paul, Koletzko, Sibylle, Kolho, Kaija-Leena, Levine, Arie, van Limbergen, Johan, Martin de Carpi, Francisco Javier, Navas-López, Víctor Manuel, Oliva, Salvatore, de Ridder, Lissy, Russell, Richard K, Shouval, Dror, Spinelli, Antonino, Turner, Dan, Wilson, David, Wine, Eytan, Ruemmele, Frank M·2021·Journal of Crohn's and Colitis

Abstract

Objective: We aimed to provide an evidence-supported update of the ECCO-ESPGHAN guideline on the medical management of paediatric Crohn’s disease [CD]. Methods: We formed 10 working groups and formulated 17 PICO-structured clinical questions [Patients, Intervention, Comparator, and Outcome]. A systematic literature search from January 1, 1991 to March 19, 2019 was conducted by a medical librarian using MEDLINE, EMBASE, and Cochrane Central databases. A shortlist of 30 provisional statements were further refined during a consensus meeting in Barcelona in October 2019 and subjected to a vote. In total 22 statements reached ≥ 80% agreement and were retained. Results: We established that it was key to identify patients at high risk of a complicated disease course at the earliest opportunity, to reduce bowel damage. Patients with perianal disease, stricturing or penetrating behaviour, or severe growth retardation should be considered for up-front anti-tumour necrosis factor [TNF] agents in combination with an immunomodulator. Therapeutic drug monitoring to guide treatment changes is recommended over empirically escalating anti-TNF dose or switching therapies. Patients with low-risk luminal CD should be induced with exclusive enteral nutrition [EEN], or with corticosteroids when EEN is not an option, and require immunomodulator-based maintenance therapy. Favourable outcomes rely on close monitoring of treatment response, with timely adjustments in therapy when treatment targets are not met. Serial faecal calprotectin measurements or small bowel imaging [ultrasound or magnetic resonance enterography] are more reliable markers of treatment response than clinical scores alone. Conclusions: We present state-of-the-art guidance on the medical treatment and long-term management of children and adolescents with CD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ecco-jcc/jjaa161

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 213 references

Cited by

See all 729

Metadata

Authors
van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., Koletzko, S., Kolho, K.-L., Levine, A., van Limbergen, J., Martin de Carpi, F. J., Navas-López, V. M., Oliva, S., de Ridder, L., Russell, R. K., Shouval, D., Spinelli, A., Turner, D., Wilson, D., Wine, E., & Ruemmele, F. M.
Venue
Journal of Crohn's and Colitis
Published
2020-10-07
Volume
15
Issue
2
Pages
171-194
ISSN
  • 1873-9946 (ISSN-L)
  • 1876-4479
OpenAlex
W3092023159
Cited by
729
References
213
FWCI
44.22
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. https://app.cochat.ai/papers/10.1093/ecco-jcc/jjaa161
The paper
van Rheenen, P. F., Aloi, M., Assa, A., Bronsky, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A., Henderson, P., Koletzko, S., Kolho, K.-L., Levine, A., van Limbergen, J., Martin de Carpi, F. J., Navas-López, V. M., Oliva, S., de Ridder, L., Russell, R. K., . . . Ruemmele, F. M. (2021). The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjaa161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.